463 related articles for article (PubMed ID: 23686786)
1. The effect of leptin, caffeine/ephedrine, and their combination upon visceral fat mass and weight loss.
Liu AG; Smith SR; Fujioka K; Greenway FL
Obesity (Silver Spring); 2013 Oct; 21(10):1991-6. PubMed ID: 23686786
[TBL] [Abstract][Full Text] [Related]
2. Energy expenditure, body composition, and glucose metabolism in lean and obese rhesus monkeys treated with ephedrine and caffeine.
Ramsey JJ; Colman RJ; Swick AG; Kemnitz JW
Am J Clin Nutr; 1998 Jul; 68(1):42-51. PubMed ID: 9665095
[TBL] [Abstract][Full Text] [Related]
3. Recombinant leptin for weight loss in obese and lean adults: a randomized, controlled, dose-escalation trial.
Heymsfield SB; Greenberg AS; Fujioka K; Dixon RM; Kushner R; Hunt T; Lubina JA; Patane J; Self B; Hunt P; McCamish M
JAMA; 1999 Oct; 282(16):1568-75. PubMed ID: 10546697
[TBL] [Abstract][Full Text] [Related]
4. The effect of ephedrine/caffeine mixture on energy expenditure and body composition in obese women.
Astrup A; Buemann B; Christensen NJ; Toubro S; Thorbek G; Victor OJ; Quaade F
Metabolism; 1992 Jul; 41(7):686-8. PubMed ID: 1619985
[TBL] [Abstract][Full Text] [Related]
5. The effect and safety of an ephedrine/caffeine compound compared to ephedrine, caffeine and placebo in obese subjects on an energy restricted diet. A double blind trial.
Astrup A; Breum L; Toubro S; Hein P; Quaade F
Int J Obes Relat Metab Disord; 1992 Apr; 16(4):269-77. PubMed ID: 1318281
[TBL] [Abstract][Full Text] [Related]
6. Pharmacology of thermogenic drugs.
Astrup A; Toubro S; Christensen NJ; Quaade F
Am J Clin Nutr; 1992 Jan; 55(1 Suppl):246S-248S. PubMed ID: 1345887
[TBL] [Abstract][Full Text] [Related]
7. Safety and efficacy of treatment with an ephedrine/caffeine mixture. The first double-blind placebo-controlled pilot study in adolescents.
Molnár D; Török K; Erhardt E; Jeges S
Int J Obes Relat Metab Disord; 2000 Dec; 24(12):1573-8. PubMed ID: 11126208
[TBL] [Abstract][Full Text] [Related]
8. Safety and efficacy of long-term treatment with ephedrine, caffeine and an ephedrine/caffeine mixture.
Toubro S; Astrup AV; Breum L; Quaade F
Int J Obes Relat Metab Disord; 1993 Feb; 17 Suppl 1():S69-72. PubMed ID: 8384186
[TBL] [Abstract][Full Text] [Related]
9. The effect of ephedrine plus caffeine on plasma lipids and lipoproteins during a 4.2 MJ/day diet.
Buemann B; Marckmann P; Christensen NJ; Astrup A
Int J Obes Relat Metab Disord; 1994 May; 18(5):329-32. PubMed ID: 8061726
[TBL] [Abstract][Full Text] [Related]
10. A randomized double-blind placebo-controlled clinical trial of a product containing ephedrine, caffeine, and other ingredients from herbal sources for treatment of overweight and obesity in the absence of lifestyle treatment.
Coffey CS; Steiner D; Baker BA; Allison DB
Int J Obes Relat Metab Disord; 2004 Nov; 28(11):1411-9. PubMed ID: 15356670
[TBL] [Abstract][Full Text] [Related]
11. Body weight loss and weight maintenance in relation to habitual caffeine intake and green tea supplementation.
Westerterp-Plantenga MS; Lejeune MP; Kovacs EM
Obes Res; 2005 Jul; 13(7):1195-204. PubMed ID: 16076989
[TBL] [Abstract][Full Text] [Related]
12. Combination therapy with naltrexone and bupropion for obesity reduces total and visceral adiposity.
Smith SR; Fujioka K; Gupta AK; Billes SK; Burns C; Kim D; Dunayevich E; Greenway FL
Diabetes Obes Metab; 2013 Sep; 15(9):863-6. PubMed ID: 23489381
[TBL] [Abstract][Full Text] [Related]
13. The thermogenic properties of ephedrine/methylxanthine mixtures: animal studies.
Dulloo AG; Miller DS
Am J Clin Nutr; 1986 Mar; 43(3):388-94. PubMed ID: 3953478
[TBL] [Abstract][Full Text] [Related]
14. The effect of caffeine and albuterol on body composition and metabolic rate.
Liu AG; Arceneaux KP; Chu JT; Jacob G; Schreiber AL; Tipton RC; Yu Y; Johnson WD; Greenway FL; Primeaux SD
Obesity (Silver Spring); 2015 Sep; 23(9):1830-5. PubMed ID: 26239482
[TBL] [Abstract][Full Text] [Related]
15. Effects of testosterone treatment on body fat and lean mass in obese men on a hypocaloric diet: a randomised controlled trial.
Ng Tang Fui M; Prendergast LA; Dupuis P; Raval M; Strauss BJ; Zajac JD; Grossmann M
BMC Med; 2016 Oct; 14(1):153. PubMed ID: 27716209
[TBL] [Abstract][Full Text] [Related]
16. Multinutrient supplement containing ephedra and caffeine causes weight loss and improves metabolic risk factors in obese women: a randomized controlled trial.
Hackman RM; Havel PJ; Schwartz HJ; Rutledge JC; Watnik MR; Noceti EM; Stohs SJ; Stern JS; Keen CL
Int J Obes (Lond); 2006 Oct; 30(10):1545-56. PubMed ID: 16552410
[TBL] [Abstract][Full Text] [Related]
17. Enhanced weight loss with pramlintide/metreleptin: an integrated neurohormonal approach to obesity pharmacotherapy.
Ravussin E; Smith SR; Mitchell JA; Shringarpure R; Shan K; Maier H; Koda JE; Weyer C
Obesity (Silver Spring); 2009 Sep; 17(9):1736-43. PubMed ID: 19521351
[TBL] [Abstract][Full Text] [Related]
18. The acute and chronic effects of ephedrine/caffeine mixtures on energy expenditure and glucose metabolism in humans.
Toubro S; Astrup A; Breum L; Quaade F
Int J Obes Relat Metab Disord; 1993 Dec; 17 Suppl 3():S73-7; discussion S82. PubMed ID: 8124407
[TBL] [Abstract][Full Text] [Related]
19. Comparison of an ephedrine/caffeine combination and dexfenfluramine in the treatment of obesity. A double-blind multi-centre trial in general practice.
Breum L; Pedersen JK; Ahlstrøm F; Frimodt-Møller J
Int J Obes Relat Metab Disord; 1994 Feb; 18(2):99-103. PubMed ID: 8148931
[TBL] [Abstract][Full Text] [Related]
20. Insulin-leptin-visceral fat relation during weight loss.
Yip I; Go VL; Hershman JM; Wang HJ; Elashoff R; DeShields S; Liu Y; Heber D
Pancreas; 2001 Aug; 23(2):197-203. PubMed ID: 11484922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
